Bioactive compounds derived from Ganoderma lucidum exhibit anti-SARS-CoV-2 activity

Danmark Nyheder Nyheder

Bioactive compounds derived from Ganoderma lucidum exhibit anti-SARS-CoV-2 activity
Danmark Seneste Nyt,Danmark Overskrifter
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

Bioactive compounds derived from Ganoderma lucidum exhibit anti-SARS-CoV-2 activity SARSCoV2 Coronavirus Disease COVID Ganoderma lucidum triterpenoids Omicron

Study: Lucidenic acid A inhibits the binding of hACE2 receptor with spike protein to prevent SARS-CoV-2 invasion. Image Credit: sritakoset / Shutterstock

Ganoderma lucidum is a widely-used Chinese medicinal fungus belonging to the Polyporaceae family. Bioactive compounds isolated from this fungus have shown potent immune-enhancing and antiviral activities. A network model of potential antiviral target genes of Ganoderma lucidum was created, which included the targets related to inflammation, infection, cancer, and other pathways. Based on the activities of identified targets, scientists hypothesized that the bioactive compounds could be used to treat SARS-CoV-2 infection.

Lucidenic acid A was found to interact with human ACE2 by forming a hydrogen bond, which subsequently prevented the interaction between viral spike protein and ACE2. Overall, these observations indicate that lucidenic acid A can strongly inhibit the host cell entry of wild-type SARS-CoV-2 and its variants.

Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere:

NewsMedical /  🏆 19. in UK

Danmark Seneste Nyt, Danmark Overskrifter

Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.

Q-LAAD: a dynamic, cost-effective rapid antigen test for detection of SARS-CoV-2Q-LAAD: a dynamic, cost-effective rapid antigen test for detection of SARS-CoV-2Researchers developed a high-throughput, rapid antigen SARS-CoV-2 spike protein detection test using allonamers, a new type of aptamers that carry out allosteric regulation instead of catalytic activity.
Læs mere »

COVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became availableCOVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became availableCOVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became available medrxivpreprint Columbia ColumbiaMSPH COVID19 coronavirus covid vaccination vaccine SARSCoV2
Læs mere »

What are the differences in transmissibility between novel and emerging SARS-CoV-2 variants?What are the differences in transmissibility between novel and emerging SARS-CoV-2 variants?What are the differences in transmissibility between novel and emerging SARS-CoV-2 variants? medrxivpreprint LSHTM Transmissibility COVID19 SARSCoV2 Variants
Læs mere »

Significant humoral immune evasion contributes to the emergence and rapid spread of Arg346-mutated BA.4 and BA.5 sublineagesSignificant humoral immune evasion contributes to the emergence and rapid spread of Arg346-mutated BA.4 and BA.5 sublineagesSignificant humoral immune evasion contributes to the emergence and rapid spread of Arg346-mutated BA.4 and BA.5 sublineages TheLancetInfDis immuneevasion COVID19 coronavirus covid
Læs mere »

What is the role of N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 spike maturation?What is the role of N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 spike maturation?A new study showed that SARS-CoV-2 Spike N-glycosylation patterns, intracellular lectins, and the associated molecular chaperones play crucial roles in the viral-host-cell invasion and function.
Læs mere »

A novel method to identify spike stabilizing mutations for COVID-19 vaccine developmentA novel method to identify spike stabilizing mutations for COVID-19 vaccine developmentA novel method to identify spike stabilizing mutations for COVID-19 vaccine development Coronavirus Disease COVID Vaccine SARSCoV2 UofIllinois scrippsresearch CWRUSOM
Læs mere »



Render Time: 2025-04-19 18:58:54